Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation
Version of Record online: 1 OCT 2012
© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 1, pages 100–110, January 2013
How to Cite
Isakova, T., Xie, H., Messinger, S., Cortazar, F., Scialla, J. J., Guerra, G., Contreras, G., Roth, D., Burke, G. W., Molnar, M. Z., Mucsi, I. and Wolf, M. (2013), Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation. American Journal of Transplantation, 13: 100–110. doi: 10.1111/j.1600-6143.2012.04281.x
- Issue online: 26 DEC 2012
- Version of Record online: 1 OCT 2012
- Manuscript Accepted: 19 AUG 2012
- Manuscript Revised: 10 AUG 2012
- Manuscript Received: 3 JUL 2012
- NIH. Grant Numbers: K23DK087858, R01DK076116, R01DK081374
- Health Resources and Services Administration. Grant Number: 234-2005-37011C
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
Table S1. Risks of death among users of mTORI only in the overall study population
Table S2. Risks of death-censored allograft failure, death and their composite in the overall study population during years 2–8 following adjustment for acute rejection in the first year.
Table S3. Patient characteristics according to treatment status in the matched cohort
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.